Annovis Bio, Inc. - 8-K Filing

Annovis Bio receives NYSE notice of non-compliance with continued listing standards due to market capitalization and stockholders' equity deficiencies. (Items: 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, 7.01 Regulation FD Disclosure The Company issued a press release announcing the receipt of the Notice, 9.01 Financial Statements and Exhibits Exhibit Number Description 99)

SEC EDGAR ·

Tickers: $ANVS

Read the full article at SEC EDGAR

More Regulatory news